REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Walleye Capital LLC 4,500$113,8950.00%
Citadel Advisors 59,299$1,500,8580.00%
ENVESTNET ASSET MANAGEMENT INC 25,502$645,4560.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 33,312$843,1270.00%
IFP Advisors, Inc 150$4,0500.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 50$1,2660.00%
MASSMUTUAL TRUST CO FSB/ADV 114$2,8850.00%
NISA INVESTMENT ADVISORS, LLC 720$18,2230.00%
FEDERATED HERMES, INC. 6,443$163,0720.00%
CANADA LIFE ASSURANCE Co 3,225$820.00%
CWM, LLC 173$40.00%
TORONTO DOMINION BANK 5$00.00%
Allworth Financial LP 132$3,3420.00%
ROYAL BANK OF CANADA 42,710$1,082,0000.00%
ASSETMARK, INC 1,996$50,5190.00%
MILLENNIUM MANAGEMENT LLC 37,300$944,0630.00%
CENTRAL TRUST Co 50$1,2660.00%
US BANCORP \DE\ 3,215$81,3720.00%
PNC FINANCIAL SERVICES GROUP, INC. 429$10,8590.00%
Point72 Asset Management, L.P. 3,100$78,4610.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.